Patent · US Expired

MAGE-A4 antigenic peptides and uses thereof

US7311914B2 · kind B2 · utility

63Cited by

9References

11Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Yi Zhang · Edison, US
Vincent Stroobant · Brussels, BE
Vincenzo Russo · Roma, IT
Thierry Boon-Falleur · Brussels, BE
Pierre van der Bruggen · Brussels, BE

Key dates

Filing date	Aug 13, 2002
Grant date	Dec 25, 2007
Priority date	—
Expiry date	Jun 19, 2024

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/6893
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention provides antigenic peptides derived from MAGE polypeptides and presented by HLA-B37 molecules. Methods for diagnosis and treatment which involve the polypeptides also are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.